In order to determine if the decreased expression of ELA2 in lin-CD34+ cells from CML patients is associated with methylation of the promoter region, we isolated DNA from normal and CML patient samples. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.